| Literature DB >> 35046212 |
Takeshi Tsuka1, Tomokazu Kozu2, Yuji Sunden1, Takehito Morita1, Yoshiharu Okamoto1, Masamichi Yamashita1, Tomohiro Osaki1, Takao Amaha1, Norihiko Ito1, Yusuke Murahata1, Tomohiro Imagawa1.
Abstract
A 21-year-old female spotted seal (Phoca largha), with a swollen abdomen, had a five-month history of anorexia and vomiting. Ultrasonography revealed an extended mass with central necrotic foci in the right cranial abdomen. Computed tomography revealed an abdominal mass with a low-density central lumen and a pulmonary nodular lesion. Cytology of an abdominal specimen collected through fine-needle aspiration indicated a malignant tumor with round, atypical cells with large nuclei. Three days after diagnosis, necropsy revealed a 10-cm large, solid, whitish mass in the pancreatic parenchyma and multiple small nodules in the liver, spleen, mesentery, lungs, and mediastinal lymph nodes. Histopathological analysis showed prolific neoplastic cells with marked atypia and occasional keratinization. Immunohistochemistry revealed that the neoplastic cells were positive for cytokeratin AE1/AE3 antibody. Thus, the seal was diagnosed with squamous cell carcinoma, of presumed pancreatic origin, which had metastasized to multiple organs.Entities:
Keywords: computed tomography; pancreas; spotted seal (Phoca largha); squamous cell carcinoma; ultrasonography
Mesh:
Year: 2022 PMID: 35046212 PMCID: PMC8983291 DOI: 10.1292/jvms.21-0156
Source DB: PubMed Journal: J Vet Med Sci ISSN: 0916-7250 Impact factor: 1.267
Hematological and serum biochemical values
| Variable | This case | Reference range [ | Reference range [ |
|---|---|---|---|
| Red blood cell count (×104/µl) | 329 | 390–570 | 390–550 |
| White blood cell count (/µl) | 10,600 | 6,000–14,200 | 7,500–18,900 |
| Hemoglobin (g/dl) | 13.7 | 13.5–24.0 | 14.3–22.9 |
| Hematocrit (%) | 33.8 | 35–63 | 39–62 |
| Total protein (g/dl) | 9.6 | 6.7–8.4 | 5.7–8.9 |
| Albumin (g/dl) | 4.1 | - | - |
| Urea nitrogen (mg/dl) | 40.5 | 22.4–41.5 | 8.1–35.6 |
| Creatinine (mg/dl) | 0.5 | 0.8–1.3 | 0.3–1.1 |
| Alkaline phosphatase (U/l) | 172 | 20–84 | 23–259 |
| Aspartate aminotransferase (U/l) | 122 | 5–91 | 45–221 |
| Alanine aminotransferase (U/l) | 14 | 6–90 | 36–69 |
| Total cholesterol (mg/dl) | 360 | 209–321 | 213–302 |
| Glucose (mg/dl) | 161 | 124–177 | 87–186 |
| Sodium (mmol/l) | 148 | 147–158 | 144–156 |
| Chloride (mmol/l) | 107 | 101–112 | 99–111 |
| Potassium (mmol) | 4.5 | 2.8–4.6 | 3.9–5.9 |
Fig. 1.Ultrasonogram (a), computed tomographic image (b), and macroscopic view (c) of the mass lesion (M) in the pancreas. (a) An echogenic mass (M) is seen at sites deeper than the skin, subcutaneous tissues (S), liver (L), and large blood vessels (V). The mass includes a hypoechoic cavity (asterisk) in the center. (b) A mass (M) is seen in the space between the stomach (S) and liver (L), and it features a low-density lumen (asterisk) in the center. Scale=25 mm. (c) A whitish, round mass (arrowheads) is seen to protrude from the pancreas (P). D, duodenum. Bar=5 cm.
Fig. 2.(a) Cytology of a pancreatic mass specimen obtained via ultrasound-guided fine-needle aspiration. Light Giemsa stain. (b) Low-magnification histopathological view of the mass (M) and pancreas (P). Proliferation of epithelial neoplastic cells with eosinophilic debris and some inflammatory cells are evident. Infiltration of some neoplastic cells occurs within the fibrous capsules (C). Hematoxylin and eosin stain. Bar=500 µm. (c) High-magnification histopathological view of the pancreatic mass. Neoplastic cells occasionally show keratinization (arrows) and mitotic figures (arrowheads). Bar=50 µm. (d) High-magnification histopathological view of the mediastinal lymph node. The neoplastic cells show marked atypia and many mitotic figures (arrowheads). Bar=50 µm. (e) High-magnification histopathological view of the mediastinal lymph node. The neoplastic cells sometimes show intercellular bridges (arrows). Bar=10 µm. (f) High-magnification immunohistochemical view of the pancreatic mass. The neoplastic cells are immunopositive for cytokeratin antibody (AE1/AE3). Bar=50 µm.